Suicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy

Suicide Risk in Adolescents During the COVID-19 Pandemic

(2022) John D. Lantos et al.   PEDIATRICS

Lived experiences of individuals with cystic fibrosis on CFTR-modulators

(2022) Annelise Page et al.   BMC Pulmonary Medicine

Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis

(2022) Spoletini G et al.   Journal of Cystic Fibrosis

Elexacaftor‐Tezacaftor‐Ivacaftor Overdose in an Adolescent Female with Cystic Fibrosis

(2022) Benjamin C. Lyman et al.   PEDIATRIC PULMONOLOGY

The impact of COVID-19 lockdown on child and adolescent mental health: systematic review

(2021) Urvashi Panchal et al.   EUROPEAN CHILD & ADOLESCENT PSYCHIATRY

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes

(2021) Peter J. Barry et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impact of COVID-19 on mental health: Effects on screening, care delivery, and people with cystic fibrosis

(2021) Beth A. Smith et al.   Journal of Cystic Fibrosis

296: Mental health implications of genetic modulator therapy in CF: Depression and anxiety screening for pediatric patients prescribed elexacaftor/tezacaftor/ivactor during the COVID-19 pandemic

(2021) T. Vance et al.   Journal of Cystic Fibrosis

Mental status changes during elexacaftor/tezacaftor / ivacaftor therapy

(2021) Suyeon Heo et al.   Journal of Cystic Fibrosis

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

(2021) Sivagurunathan Sutharsan et al.   Lancet Respiratory Medicine

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020

(2020) Mark É. Czeisler et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review

(2020) Renée V. E. Dagenais et al.   Journal of Clinical Medicine

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

(2015) Alexandra L Quittner et al.   THORAX

Depression, illness severity, and healthcare utilization in cystic fibrosis

(2014) Carolyn Snell et al.   PEDIATRIC PULMONOLOGY

Expression and Distribution of Cystic Fibrosis Transmembrane Conductance Regulator in Neurons of the Human Brain

(2009) Yong Guo et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Prevalence and impact of depression in cystic fibrosis

(2008) Alexandra L Quittner et al.   CURRENT OPINION IN PULMONARY MEDICINE